New York Mercantile Exchange › MINY SILVER Jul 2013 (E) (NYMEX:QI.N13.E)
22.4750 +0.0250 (+0.11%)
2013-05-22 14:07:51, 30 min delay
| Last Price | 22.4750 |
|---|---|
| Settle Time | 15:31 |
| Previous Close | 22.3125 |
| Low | 22.2000 |
| Open Int. | 184 |
| Contract High | 34.15 |
| Contract Low | 20.3125 |
| Estimated Volume | 99 |
| Open Time | 18:00 |
| Net Change | 0.0250 |
|---|---|
| Open | 22.5875 |
| High | 23.2625 |
| Volume | 93 |
| Time | 2013-05-22 14:07:51 |
| Contract High Date | 2012-11-23 |
| Contract Low Date | 2013-05-20 |
| Expiration | 2013-06-26 |
| Close Time | 17:15 |
Today's Top 50 Trending Stocks: Let our SmartScan and Trade Triangle technology, brought to you courtesy of our premium service MarketClub, instantly rank today's top 50 stocks for you. This complimentary list will update throughout the day to highlight the most timely trading opportunities.
Trader's Blog
Today's Video Update: Target And Lowe's Both Miss... Who's Next?
6 hours ago
Is Wal-Mart the "Canary in the Mine"?
11 hours ago
Poll: What do you think of U.S. taxes?
1 day ago
Supercharge Your Portfolio With These Powerful ETFs
1 day ago
Today's News
How the Dow Jones industrial average fared
2 hours, 48 minutes ago
Stock indexes fell on Wall Street on fear the Federal Reserve could pull back from its stimulus programs soon. After surging early in the day, stocks fell as investors digested minutes of a Fed meeting that suggested the stimulus could be scaled back as early as next month if the economy picks up. The Dow Jones industrial average fell 80.41 points, or 0.5 percent, to close at 15,307.17.
AP Top Extended Financial Headlines At 5:46 p.m. EDT
2 hours, 44 minutes ago
Stocks fall, interest rates rise after Fed minutes show policymakers weighed stimulus pullback Fed appears divided over when to slow bond purchases; some would consider a pullback soon
AP Top Financial News At 5:46 p.m. EDT
2 hours, 46 minutes ago
Stocks fall on news Fed weighed cutting stimulus Median CEO pay rises to $9.7 million in 2012 A divided Fed wrestles with when to slow bond buys
FDA panel backs experimental Merck insomnia drug
2 hours, 50 minutes ago
A federal panel of medical experts said that an experimental insomnia drug from Merck & Co. Inc. appears safe and effective, despite evidence from company trials that the pill can cause daytime sleepiness and difficulty driving. The FDA is not required to follow the recommendations of its experts, though it often does.
